The Saint Louis University Division of Gastroenterology and Hepatology has a long history of excellence in clinical care, education and research.
Our division has the SLU Liver Center, the Gastrointestinal Motility Center and a Center for Pancreatic and Biliary Disorders. Our SLUCare Center for Pancreatic and Biliary Diseases is one of only 30 National Pancreas Foundation Centers, recognized for excellence in treating pancreatic diseases. The division interacts closely with the Center for Abdominal Transplant.
Our mission is to provide the best clinical care to our patients, an excellent education for our medical students, residents, subspecialty residents and community physicians, and to continue to advance knowledge in gastroenterology and hepatology through cutting-edge clinical and basic research.
Our faculty are experts in their fields and are nationally and internationally recognized for their outstanding contributions to the practice of gastroenterology and hepatology. Our clinical practice treats patients with inflammatory bowel disease, complicated motility disorders, pancreatic and biliary disease, and all forms of liver diseases including hepatitis, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), primary biliary cirrhosis (PBC), sclerosing cholangitis (PSC), hepatocellular carcinoma, liver transplantation (pre- and post-transplant) and hemochromatosis
Our advanced endoscopists treat patients with pancreatic, biliary and gallbladder disorders, and gastrointestinal malignancies. We use state-of-the-art equipment to do endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and other advanced interventional and therapeutic endoscopic procedures.
Our gastroenterologists treat patients with gastrointestinal disorders such as ulcerative colitis, Crohn’s disease, abdominal pain, GERD, diverticulitis, diverticulosis, diarrhea, lactose intolerance, constipation, peptic ulcers, celiac disease, and motility disorders. They perform diagnostic procedures such as colonoscopy and endoscopy using advance techniques including variceal band ligation, mucosal ablation, argon plasma coagulation, endoscopic mucosal resection, and removal of complex polyps. Procedures also include advanced techniques in motility measurement, pH and impedance monitoring.
We have a very active gastroenterology and hepatology research unit where our NIH and industry-sponsored studies are performed. The division has several state-of-the art basic research laboratories where our basic science faculty members conduct research to understand the basis for diseases that affect the liver, pancreas, and GI tract.
The Division of Gastroenterology and Hepatology has an outstanding three-year fellowship program to train future gastroenterologists and hepatologists. Our fellows have historically had a 100 percent pass rate when they take their boards.
Endowed Chair in Gastroenterology
Prompted by the gratitude for the medical education he received at Saint Louis University School of Medicine and his pride in the division’s accomplishments, James F. King, M.D., funded the first endowed chair in gastroenterology at Saint Louis University School of Medicine to recognize the expertise and leadership of key members of the Division.
Clinical Trials and Studies
The Division of Gastroenterology and Hepatology at Saint Louis University has led the nation in enrollment in large, multicenter clinical trials, and is a recognized leader in both clinical and laboratory based research in liver disease. Clinical research in liver disease is conducted in the GI/Hepatology Studies Unit and the NIH Clinical Studies Unit on the second floor of the Saint Louis University Salus Center.
GI/Hepatology Clinical Studies Unit
Our GI/Hepatology clinical studies unit sees many patients each month who are enrolled in ongoing industry and NIH sponsored research protocols. Currently, there are multiple active clinical protocols with more new clinical trials pending site initiation. These trials currently include the following areas of research:
Primary biliary cirrhosis
Primary sclerosing cholangitis
Irritable bowel syndrome (IBS)
Fatty liver disease (NASH)
Ongoing clinical research activities allow patients to be included in protocols evaluating new therapies. The clinical studies unit staff includes full-time certified research nurse coordinators, data coordinators, regulatory staff, phlebotomists, and a nurse manager.
For information regarding clinical trials, call the GI/Hepatology Clinical Studies Unit at 314-977-9400 to speak with a research coordinator.